Delivery Order SPE2DB22D1202-SPE2DB24FVLW4
Award Date
8/23/24
Potential Completion Date
8/26/24
Potential Value
$1.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the supply of Vyvanse 50 mg capsules (100s) to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for a ceiling value of $5,343.24 and has an ultimate completion date of August 21, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical,...
This federal contract award is for the delivery of Vyvanse 50 mg capsules to the U.S. government. The $1,116.46 contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with the DLA Troop Support Medical, which serves as the primary vehicle for Amerisourcebergen to supply a comprehensive range of...
This federal contract award is for the delivery of Vyvanse (lisdexamfetamine dimesylate) 30mg capsules. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The total ceiling value of the contract is $14,244.32, with a completion date of December 15, 2023. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with...
This federal contract award is for the delivery of Vyvanse (lisdexamfetamine dimesylate) 40 mg capsules in quantities of 100 per bottle. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. This is a firm-fixed-price delivery order with a ceiling value of $1,598.89 and an ultimate completion date of October 28, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a...
This federal contract award is for the delivery of Vyvanse 50 mg capsules to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on March 24, 2025 for a ceiling value of $4,906.88. It is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is March 25, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite...
This federal contract award is for the delivery of Vyvanse 40mg capsules to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through November 2026. This IDC enables the efficient procurement of a broad range of pharmaceutical products and medical supplies to...
This federal contract award is for the delivery of Vyvanse 50 mg capsules to the U.S. government. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $1,402.14, is a delivery order placed under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00 through December 2025. This IDC serves as the primary vehicle for...
The federal contract award is for the delivery of Vyvanse 30 mg capsules to the Defense Logistics Agency (DLA), a major defense agency of the U.S. government. The $3,488.60 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corporation, a large pharmaceutical distributor. This contract is a child of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a...
This federal contract award is for the delivery of Vyvanse 30mg capsules to the Defense Logistics Agency (DLA), a defense agency under the Department of Defense. The contract, valued at $8,496.04, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on September 9, 2024, with a completion date of September 10, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen, through its extensive supply chain network, will...
This federal contract award is for the delivery of Vyvanse 50 mg capsules to the Defense Logistics Agency (DLA). The contract, valued at $1,851.03, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a...